Hindson Benjamin J. 的 Form 4 申報
10x Genomics, Inc.（TXG），2021/11/3 申報
- 申報編號
- 0001567619-21-019297
- 申報時間
- 2021/11/3
- 交易日
- 2021/11/1
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 7 筆非衍生性交易、2 筆衍生性交易。公開市場賣出合計 $681.6 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Hindson Benjamin J.CIK 0001786391 | 董事、高階主管（見申報備註） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/11/1 | Class A Common Stock | M行使選擇權取得 | +10,232 | $5.04 | +$51,569.28 | 57,349 | 直接 | |
| 2021/11/1 | Class A Common Stock | M行使選擇權取得 | +31,434 | $11.48 | +$360,862.32 | 88,783 | 直接 | |
| 2021/11/1 | Class A Common Stock | S賣出處分 | −1,100 | $160.50F2 | −$176,550 | 87,683 | 直接 | |
| 2021/11/1 | Class A Common Stock | S賣出處分 | −1,500 | $162.06F3 | −$243,090 | 86,183 | 直接 | |
| 2021/11/1 | Class A Common Stock | S賣出處分 | −11,829 | $163.15F4 | −$1,929,901.35 | 74,354 | 直接 | |
| 2021/11/1 | Class A Common Stock | S賣出處分 | −24,125 | $163.87F5 | −$3,953,363.75 | 50,229 | 直接 | |
| 2021/11/1 | Class A Common Stock | S賣出處分 | −3,112 | $164.75F6 | −$512,702 | 47,117 | 直接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2021/11/1 | Class A Common Stock | M行使選擇權處分 | −10,232 | $0.00 | $0 | 50,884 | 直接 | |
| 2021/11/1 | Class A Common Stock | M行使選擇權處分 | −31,434 | $0.00 | $0 | 68,566 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
This transaction was executed in multiple trades at prices ranging from $160.00 to $160.95. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
This transaction was executed in multiple trades at prices ranging from $161.45 to $162.43. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $162.48 to $163.475. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
This transaction was executed in multiple trades at prices ranging from $163.48 to $164.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
This transaction was executed in multiple trades at prices ranging from $164.50 to $165.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
表 I 有 1 筆交易的價格引用這則附註。
備註
Chief Scientific Officer and President